Making gene and cell therapy possible: Viruses
So, we understand the problem. How do we fix it? Author: Alexander T. Baker, Senior Scientist, Accession Therapeutics Years of…
Researcher in the Spotlight: Alexandros Angelopoulos, Northumbria University
This month’s ‘researcher in the spotlight’ is BSGCT mentee, Alexandros Angelopoulos, Northumbria University. Can you tell us about your research…
Down but not out: how adenoviral vaccines may still save the day.
Authors: Prof Alan Parker, February 2022. In late 2019, the world could never have foreseen the impact that a new,…
An update on gene therapy for Spinal muscular atrophy
Author: Dr Rajvinder Karda, University College London, 16 December 2021 Rare disease is defined by the European Commission on Public…
First in man in vivo delivery of CRISPR-Cas9 targeting Transthyretin Amyloidosis
Authors: Dr Christos Georgiadis, October 2021. While this year has to most felt as though life came to a standstill,…
Vaccines for COVID-19
Author: Prof. Rafael J. Yáñez-Muñoz, Royal Holloway University of London, 30 August 2021 Vaccines are very much still a hot…
A Commentary on Vaccine-Induced Immune Thrombotic Thrombocytopenia
Authors: Miss Caitlin Dop and Dr Carly Bliss, May 2021. In response to the SARS-CoV-2 pandemic, a number of COVID-19…
See you LATER to pain
Author: Robyn Bell, Imperial College London, 19 May 2021 Chronic pain has a high prevalence globally, with estimates of 20-30%…
Addressing the challenge of informing the wider population on advances in gene and cell therapy
Author: Gerry McLachlan, 3rd March 2021 The role for the BSGCT in engaging with the public is becoming ever more…
Precision genome editing for mitochondrial DNA – Mission accomplished?
Author: Anitta Rose Chacko Technologies such as CRISPR have revolutionised precision genome editing and paved the way for treatment of…
Switching Up T Cell Therapies
Author: Katie Dale With the huge effort that’s currently being spent developing more resistant T cell therapies with new targets…
Could It Be A One-Stop Solution For The Most Common Cause Of Irreversible Blindness?
By Vered Smith Glaucoma is a condition that affects approximately 70 million people worldwide¹, –a number greater than all the…